- Germany's Degussa Group, a dealer in metals and manufacturers of chemicals and pharmaceuticals, posted results for the nine months to June 30, 1995, that showed sales up 3% to 10.5 billion Deutschemarks ($7.3 billion) and income before taxes of 281 million marks, a rise of 51% on the like, year-earlier period. Sales in the pharmaceutical sector were down 1% to 1.63 billion marks, which, according to the group, was due to the effect of lower gold quotations on its dental business. Without the precious metal influences, the group says that sales would have risen by 2%. In addition, the Asta Medica Group recorded sales that were significantly higher than the like, 1994 period.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze